AzTrials
AzTrials

OsteoarthritisPhase 3CARAKANCT01225133

Complex Āyurvedic Treatment in Osteoarthritis of the Knee Compared to Standard Care.

A Phase 3 study testing Complex Ayurvedic Treatment and Conventional Care in people with Osteoarthritis, run by Charite University, Berlin, Germany at 2 sites in Germany.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of this study is to evaluate the effectiveness of a complex āyurvedic diagnosis and treatment compared to conventional standard care in patients with OA of the knee. Read more about this study

Who is it for?
Ages 40 to 70 years
Conditions the study is for
Osteoarthritis
What is being tested?
Complex Ayurvedic Treatment and Conventional Care
Could I receive a placebo?
No, everyone receives an active treatment
How many people
150 participants
Where
2 sitesGermany
Study dates
Oct 2010to Mar 2015
Phase
Phase 3
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 to 70 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Male and female patients,
  • Age 40-70 years,
  • Prediagnosed, confirmed and documented diagnosis of OA of the knee. Diagnosis performed by a medical specialist (orthopedic surgeon, surgeon, radiologist) according to the American College of Rheumatology criteria,
  • Documented radiologic changes of the knee-joint Kellgren-Lawrence criteria > or = grade 2 in conventional X-ray or MRI-scan,
  • Mean average pain intensity of 40 or more on two 100 mm visual analogue scales in the 7 days before baseline assessment,
  • Written informed consent.

Who cannot join

  • Pain in the knee caused by oCongenital dysplasia of the affected knee oRheumatoid arthritis oAutoimmune diseases oMalignancies oStatus post Knee surgery oStatus post Arthroscopy
  • Administration of chondroprotective drugs in the preceding 3 months,
  • Intra-articular injection into the affected knee-joint during the preceding 3 months,
  • Beginning of a systemic medication with corticosteroids within the preceding three months,
  • Beginning of any new treatment for OA during the previous 4 weeks (with the exception of analgesic treatment with Paracetamol or NSAIDs),
  • Pregnancy or breastfeeding,
Show all 17Show fewer
  • Acute mental disorders,
  • Serious acute organic diseases,
  • Serious chronic co-morbidity,
  • Obesity WHO-grade II/III
  • Blood coagulation disorders,
  • Coagulation-inhibiting medication other than Aspirin and Clopidogrel,
  • Invasive measures performed at the affected joint during the previous 12 weeks or planned within the following 12 month,
  • In the process of applying for pension or disability benefits,
  • Simultaneous participation in any other clinical trial,
  • Participation in a clinical trial during the 6 month before inclusion into this trial,
  • Missing of the written informed consent form.

Trial locations and contacts

2 sites in 1 country.

Germany2 sites
  • Charité Medical University Cooperation Center Sonne und Mond

    Berlin, State of Berlin, 10119

  • Immanuel Krankenhaus

    Berlin, State of Berlin, 14109

Other trials in Germany

About this study

Official title: The CARAKA-Trial: Complex Āyurvedic Treatment in Osteoarthritis of the Knee Against Standard Care.A Multicentre, Randomized, Controlled Clinical Trial Based on Traditional Āyurveda-Diagnosis.

The aim of this study is to evaluate the effectiveness of a complex āyurvedic diagnosis and treatment compared to conventional standard care in patients with OA of the knee.

Conditions
Osteoarthritis
Being tested
Complex Ayurvedic Treatment, Conventional Care
Keywords
Osteoarthritis, Osteoarthrosis, Arthritis, Arthrosis
Medical subject headings
Osteoarthritis, Arthritis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Complex Ayurvedic TreatmentOther

    In the Āyurveda group treatment will be individualized according to the Āyurveda diagnosis and include manual treatments, massages, dietary advice, specific consideration of selected food items, nutritional supplements, āyurvedic lifestyle and yoga posture advice and daily self-applied knee massage.

  • Conventional CareOther

    Patients in the conventional standard care group will receive conventional standard care for OA of the Knee which includes self care advice, pain medication and intensified physiotherapy and follows the current international guidelines for OA of the knee.

Study groups in NCT01225133
Study groupRoleWhat they receive
Complex Ayurvedic TreatmentActive comparatorIn the Āyurveda arm treatment will be individualized according to the Āyurveda diagnosis and include manual treatments, massages, dietary advice, specific consideration of selected food items, nutritional supplements, āyurvedic lifestyle and yoga posture advice and daily self-applied knee massage.
Receives: Other: Complex Ayurvedic Treatment; Other: Conventional Care
Conventional CareActive comparatorPatients in the conventional standard care group will receive conventional standard care for OA of the Knee which includes self care advice, pain medication and intensified physiotherapy and follows the current international guidelines for OA of the knee.
Receives: Other: Complex Ayurvedic Treatment; Other: Conventional Care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Western Ontario and McMaster University Osteoarthritis Index (WOMAC)

    Measured: week 12

Secondary outcomes (11)
  1. Western Ontario and McMaster University Osteoarthritis Index (WOMAC) Subscales

    Measured: month 6

  2. SF-36-questionnaire

    Measured: week 12

  3. POMS-questionnaire

    Measured: week 12

  4. Visual Analogue Scales: Pain

    Measured: week 12

  5. Visual Analogue Scales: Sleep

    Measured: week 12

  6. Western Ontario and McMaster University Osteoarthritis Index (WOMAC) Subscales

    Measured: month 12

  7. SF-36-questionnaire

    Measured: month 6

  8. SF-36-questionnaire

    Measured: month 12

  9. Western Ontario and McMaster University Osteoarthritis Index (WOMAC) Subscales

    Measured: week 12

  10. POMS-questionnaire

    Measured: month 6

  11. POMS-questionnaire

    Measured: month 12

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Oct 2010 (estimated)
  2. Study startOct 2010
  3. Primary completionJul 2014
  4. Study completionMar 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 3
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
150 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01225133
Sponsor's protocol ID
CARAKA-1
Acronym
CARAKA
Status last verified
Mar 2015
First submitted
6 Oct 2010
Last updated
31 Mar 2015
Results posted
No
Data monitoring committee
Yes

Publications

  • Kessler CS, Dhiman KS, Kumar A, Ostermann T, Gupta S, Morandi A, Mittwede M, Stapelfeldt E, Spoo M, Icke K, Michalsen A, Witt CM. Effectiveness of an Ayurveda treatment approach in knee osteoarthritis - a randomized controlled trial. Osteoarthritis Cartilage. 2018 May;26(5):620-630. doi: 10.1016/j.joca.2018.01.022. Epub 2018 Feb 7.

    PubMed 29426006
  • Witt CM, Michalsen A, Roll S, Morandi A, Gupta S, Rosenberg M, Kronpass L, Stapelfeldt E, Hissar S, Muller M, Kessler C. Comparative effectiveness of a complex Ayurvedic treatment and conventional standard care in osteoarthritis of the knee--study protocol for a randomized controlled trial. Trials. 2013 May 23;14:149. doi: 10.1186/1745-6215-14-149.

    PubMed 23701973

Questions about this trial

What is this clinical trial studying?

A Phase 3 study testing Complex Ayurvedic Treatment and Conventional Care in people with Osteoarthritis, run by Charite University, Berlin, Germany at 2 sites in Germany.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 17 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 31 Mar 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Western Ontario and McMaster University Osteoarthritis Index (WOMAC) (time frame: week 12). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01225133, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Mar 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in